MedTrace Logo

Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection

NCT00828360 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2009-01-23

No results posted yet for this study

Summary

While cardiac resynchronization therapy (CRT) has a well demonstrated therapeutic effect in selected patients with advanced heart failure (HF) on optimized drug therapy, non-responder rate remains high. The low-dose dobutamine stress-echo (DSE) test to predict positive response to CRT (LODO-CRT) trial is designed to improve patient selection for CRT.

Conditions

Sponsors & Collaborators

  • Ospedale Santa Maria di Loreto Mare

    lead OTHER

Principal Investigators

  • Carmine Muto, MD · Ospedale Santa Maria di Loreto Mare Naples

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2009-04-30
Completion
2009-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828360 on ClinicalTrials.gov